|
1
|
Kavitt RT, Lipowska AM, Anyane-Yeboa A and
Gralnek IM: Diagnosis and treatment of peptic ulcer disease. Am J
Med. 132:447–456. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Lau JY, Barkun A, Fan DM, Kuipers EJ, Yang
YS and Chan FK: Challenges in the management of acute peptic ulcer
bleeding. Lancet. 381:2033–2043. 2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Dadfar A and Edna TH: Epidemiology of
perforating peptic ulcer: A population-based retrospective study
over 40 years. World J Gastroenterol. 26:5302–5313. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Thorsen K, Søreide JA, Kvaløy JT,
Glomsaker T and Søreide K: Epidemiology of perforated peptic ulcer:
Age- and gender-adjusted analysis of incidence and mortality. World
J Gastroenterol. 19:347–354. 2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Malfertheiner P, Chan FK and McColl KE:
Peptic ulcer disease. Lancet. 374:1449–1461. 2009.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zheng Y, Xue M, Cai Y, Liao S, Yang H,
Wang Z, Wang X, Zhang X, Qian J and Wang L: Hospitalizations for
peptic ulcer disease in China: Current features and outcomes. J
Gastroenterol Hepatol. 35:2122–2130. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ford AC, Delaney BC, Forman D and Moayyedi
P: Eradication therapy in Helicobacter pylori positive
peptic ulcer disease: Systematic review and economic analysis. Am J
Gastroenterol. 99:1833–1855. 2004.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Treiber G and Lambert JR: The impact of
Helicobacter pylori eradication on peptic ulcer healing. Am
J Gastroenterol. 93:1080–1084. 1998.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Sung JJ, Kuipers EJ and El-Serag HB:
Systematic review: The global incidence and prevalence of peptic
ulcer disease. Aliment Pharmacol Ther. 29:938–946. 2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kamada T, Satoh K, Itoh T, Ito M, Iwamoto
J, Okimoto T, Kanno T, Sugimoto M, Chiba T, Nomura S, et al:
Evidence-based clinical practice guidelines for peptic ulcer
disease 2020. J Gastroenterol. 56:303–322. 2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Savarino V, Mela GS, Zentilin P, Bisso G,
Pivari M, Vigneri S, Termini R, Fiorucci S, Usai P, Malesci A and
Celle G: Comparison of 24-h control of gastric acidity by three
different dosages of pantoprazole in patients with duodenal ulcer.
Aliment Pharmacol Ther. 12:1241–1247. 1998.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Lamers CB: The changing role of
H2-receptor antagonists in acid-related diseases. Eur J
Gastroenterol Hepatol. 8 (Suppl 1):S3–S7. 1996.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ji XQ, Du JF, Chen G, Chen G and Yu B:
Efficacy of ilaprazole in the treatment of duodenal ulcers: A
meta-analysis. World J Gastroenterol. 20:5119–5123. 2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Poynard T, Lemaire M and Agostini H:
Meta-analysis of randomized clinical trials comparing lansoprazole
with ranitidine or famotidine in the treatment of acute duodenal
ulcer. Eur J Gastroenterol Hepatol. 7:661–665. 1995.PubMed/NCBI
|
|
15
|
Eriksson S, Långström G, Rikner L,
Carlsson R and Naesdal J: Omeprazole and H2-receptor antagonists in
the acute treatment of duodenal ulcer, gastric ulcer and reflux
oesophagitis: A meta-analysis. Eur J Gastroenterol Hepatol.
7:467–475. 1995.PubMed/NCBI
|
|
16
|
Bamberg P, Caswell CM, Frame MH, Lam SK
and Wong EC: A meta-analysis comparing the efficacy of omeprazole
with H2-receptor antagonists for acute treatment of duodenal ulcer
in Asian patients. J Gastroenterol Hepatol. 7:577–585.
1992.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Hou XH, Meng F, Wang J, Sha W, Chiu CT,
Chung WC, Gu L, Kudou K, Chong CF and Zhang S: 995 phase 3 Study
evaluating the efficacy and safety of Vonoprazan 20 mg versus
lansoprazole 30 mg in the treatment of endoscopically confirmed
duodenal ulcers in Asian subjects with or without Helicobacter
pylori infection. Gastroenterology. 158:S197–S198. 2020.
|
|
18
|
Hawkey CJ, Long RG, Bardhan KD, Wormsley
KG, Cochran KM, Christian J and Moules IK: Improved symptom relief
and duodenal ulcer healing with lansoprazole, a new proton pump
inhibitor, compared with ranitidine. Gut. 34:1458–1462.
1993.PubMed/NCBI View Article : Google Scholar
|
|
19
|
McFarland RJ, Bateson MC, Green JR,
O'Donoghue DP, Dronfield MW, Keeling PW, Burke GJ, Dickinson RJ,
Shreeve DR, Peers EM, et al: Omeprazole provides quicker symptom
relief and duodenal ulcer healing than ranitidine.
Gastroenterology. 98:278–283. 1990.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Chaimani A, Caldwell DM, Li T, Higgins JPT
and Salanti G: Additional considerations are required when
preparing a protocol for a systematic review with multiple
interventions. J Clin Epidemiol. 83:65–74. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Cumpston M, Li T, Page MJ, Chandler J,
Welch VA, Higgins JP and Thomas J: Updated guidance for trusted
systematic reviews: A new edition of the Cochrane Handbook for
systematic reviews of interventions. Cochrane Database Syst Rev.
10(ED000142)2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Salanti G, Del Giovane C, Chaimani A,
Caldwell DM and Higgins JP: Evaluating the quality of evidence from
a network meta-analysis. PLoS One. 9(e99682)2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Greco T, Edefonti V, Biondi-Zoccai G,
Decarli A, Gasparini M, Zangrillo A and Landoni G: A multilevel
approach to network meta-analysis within a frequentist framework.
Contemp Clin Trials. 42:51–59. 2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Devall AJ, Papadopoulou A, Podesek M, Haas
DM, Price MJ, Coomarasamy A and Gallos ID: Progestogens for
preventing miscarriage: A network meta-analysis. Cochrane Database
Syst Rev. 4(CD013792)2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Burr NE, Gracie DJ, Black CJ and Ford AC:
Efficacy of biological therapies and small molecules in moderate to
severe ulcerative colitis: Systematic review and network
meta-analysis. Gut. 71:1976–1987. 2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Higgins JP, Jackson D, Barrett JK, Lu G,
Ades AE and White IR: Consistency and inconsistency in network
meta-analysis: Concepts and models for multi-arm studies. Res Synth
Methods. 3:98–110. 2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Chaimani A, Higgins JP, Mavridis D,
Spyridonos P and Salanti G: Graphical tools for network
meta-analysis in STATA. PLoS One. 8(e76654)2013.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Blackwood WS, Maudgal DP, Pickard RG,
Lawrence D and Northfield TC: Cimetidine in duodenal ulcer:
Controlled trial. Lancet. 2:174–176. 1976.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Gustavsson S, Adami HO, Lööf L, Nyberg A
and Nyrén O: Rapid healing of duodenal ulcers with omeprazole:
Double-blind dose-comparative trial. Lancet. 2:124–125.
1983.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Barbara L, Corinaldesi R, Bianchi Porro G,
Lazzaroni M, Blasi A, Mangiameli A, Carratelli L, Wilkins A, Cheli
R, Bovero E, et al: Famotidine in the management of duodenal ulcer:
Experience in Italy. Digestion. 32 (Suppl 1):S24–S31.
1985.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Prichard PJ, Rubinstein D, Jones DB,
Dudley FJ, Smallwood RA, Louis WJ and Yeomans ND: Double blind
comparative study of omeprazole 10 mg and 30 mg daily for healing
duodenal ulcers. Br Med J. 290:601–603. 1985.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Simon B, Dammann HG, Jakob G, Miederer SE,
Müller P, Ottenjann R, Paul F, Scholten T, Schütz E, Seifert E, et
al: Famotidine versus ranitidine for the short-term treatment of
duodenal ulcer. Digestion. 32 (Suppl 1):S32–S37. 1985.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Arcidiacono R, Benvestito V, Bonomo GM,
Bottari M, Buscarini L, Camarri E, Celle G, Coltorti M, Di Matteo
S, Dobrilla G, et al: Comparison between ranitidine 150 mg b.d. and
ranitidine 300 mg nocte in the treatment of duodenal ulcer. Int J
Clin Pharmacol Ther Toxicol. 24:381–384. 1986.PubMed/NCBI
|
|
34
|
Bardhan KD, Bianchi Porro G, Bose K, Daly
M, Hinchliffe RF, Jonsson E, Lazzaroni M, Naesdal J, Rikner L and
Walan A: A comparison of two different doses of omeprazole versus
ranitidine in treatment of duodenal ulcers. J Clin Gastroenterol.
8:408–413. 1986.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Hirschowitz BI, Berenson MM, Berkowitz JM,
Bright-Asare P, DeLuca VA Jr, Eshelman FN, Font RG, Griffin JW Jr,
Kozarek RA, McCray RS, et al: A multicenter study of ranitidine
treatment of duodenal ulcers in the United States. J Clin
Gastroenterol. 8:359–366. 1986.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Lee FI, Reed PI, Crowe JP, McIsaac RL and
Wood JR: Acute treatment of duodenal ulcer: A multicentre study to
compare ranitidine 150 mg twice daily with ranitidine 300 mg once
at night. Gut. 27:1091–1095. 1986.PubMed/NCBI View Article : Google Scholar
|
|
37
|
McCullough AJ: A multicenter, randomized,
double-blind study comparing famotidine with ranitidine in the
treatment of active duodenal ulcer disease. Am J Med. 81:17–24.
1986.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Rohner HG and Gugler R: Treatment of
active duodenal ulcers with famotidine. A double-blind comparison
with ranitidine. Am J Med. 81:13–16. 1986.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Barbara L, Blasi A, Cheli R, Corinaldesi
R, Dobrilla G, Francavilla A, Rinetti M, Vezzaldini P, Abbiati R,
Gradnik R, et al: Omeprazole vs. ranitidine in the short-term
treatment of duodenal ulcer: An Italian multicenter study.
Hepatogastroenterology. 34:229–232. 1987.PubMed/NCBI
|
|
40
|
Dobrilla G, De Pretis G, Piazzi L, Boero
A, Camarri E, Crespi M, Fontana G, Ideo G, Manenti F, Marenco G, et
al: Comparison of once-daily bedtime administration of famotidine
and ranitidine in the short-term treatment of duodenal ulcer. A
multicenter, double-blind, controlled study. Scand J Gastroenterol
Suppl. 134:21–28. 1987.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Gitlin N, McCullough AJ, Smith JL, Mantell
G and Berman R: A multicenter, double-blind, randomized,
placebo-controlled comparison of nocturnal and twice-a-day
famotidine in the treatment of active duodenal ulcer disease.
Gastroenterology. 92:48–53. 1987.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Kimmig JM: Acute therapy of duodenal
ulcer. Comparison of famotidine with ranitidine in a single evening
dosage. Fortschritte der Medizin. 105:72–76. 1987.PubMed/NCBI
|
|
43
|
Archambault AP, Pare P, Bailey RJ, Navert
H, Williams CN, Freeman HJ, Baker SJ, Marcon NE, Hunt RH,
Sutherland L, et al: Omeprazole (20 mg daily) versus cimetidine
(1200 mg daily) in duodenal ulcer healing and pain relief.
Gastroenterology. 94:1130–1134. 1988.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Hartmann H and Fölsch UR: Famotidine
versus cimetidine in the treatment of acute duodenal ulcer.
Double-blind, randomized clinical trial comparing nocturnal
administration of 40 mg famotidine to 800 mg cimetidine. Digestion.
39:156–161. 1988.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Young MD, Lottes SR and Webb LA: An
evaluation of cimetidine and ranitidine in the pain relief and
acute healing of duodenal ulcer disease. Clin Ther. 10:543–552.
1988.PubMed/NCBI
|
|
46
|
Alcalá Santaella R, Guardia J, Pajares J,
Piqué J, Pita L, Alvárez E, Castellanos P, Guarner L, Ortiz J,
Pesquera R, et al: A multicentre, randomized, double-blind study
comparing nocte famotidine or ranitidine for the treatment of
active duodenal ulceration. Aliment Pharmacol Ther. 3:103–110.
1989.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Al-Mofleh I, Mayet I, Al-Rashed R,
Al-Faleh F, Al-Aska AK and Laajam MA: Efficacy of single-daily
doses of H2-blockers in duodenal ulcer: Comparison of cimetidine
and ranitidine in a double-blind controlled trial. Curr Ther Res
Clin Exp. 46:399–403. 1989.
|
|
48
|
Chelvam P, Goh KL, Leong YP, Leela MP, Yin
TP, Ahmad H, Jalleh R, Wong NW, Lee HB and Mahendran T: Omeprazole
compared with ranitidine once daily in the treatment of duodenal
ulcer. J Gastroenterol Hepatol. 4 (Suppl 2):S53–S61.
1989.PubMed/NCBI
|
|
49
|
Crowe JP, Wilkinson SP, Bate CM,
Willoughby CP, Peers EM and Richardson PD: Symptom relief and
duodenal ulcer healing with omeprazole or cimetidine. Aliment
Pharmacol Ther. 3:83–91. 1989.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Delvaux M, Hagège CG and Ribet A:
Comparative efficacy of famotidine and ranitidine in the treatment
of acute-phase duodenal ulcer. A French comparative therapeutic
trial. Gastroenterol Clin Biol. 13:1055–1059. 1989.PubMed/NCBI
|
|
51
|
Lauritsen K, Andersen BN, Havelund T,
Laursen LS, Hansen J, Eriksen J, Jørgensen T and Rask-Madsen J:
Effect of 10 mg and 20 mg omeprazole daily on duodenal ulcer:
Double-blind comparative trial. Aliment Pharmacol Ther. 3:59–67.
1989.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Lee FI, Booth SN, Cochran KM, Crowe J,
Dickinson RJ, Kennedy NP, Cottrell J and Mann SG: Single night-time
doses of 40 mg famotidine or 800 mg cimetidine in the treatment of
duodenal ulcer. Aliment Pharmacol Ther. 3:505–512. 1989.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Mulder CJ, Tijtgat GN, Cluysenaer OJ,
Nicolai JJ, Meyer WW, Hazenberg BP, Vogten AJ, Gerrits C and
Stuifbergen WH: Omeprazole (20 mg o.m.) versus ranitidine (150 mg
b.d.) in duodenal ulcer healing and pain relief. Aliment Pharmacol
Ther. 3:445–451. 1989.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Page MC, Lacey LA, Mills JG and Wood JR:
Can higher doses of an H2-receptor antagonist accelerate duodenal
ulcer healing? Aliment Pharmacol Ther. 3:425–433. 1989.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Rodrigo L, Viver J, Conchillo F, Barrio E,
Forné M, Zozaya JM, Alvarez A, Dieguez P, Muñoz M, Panés J, et al:
A multicenter, randomized, double-blind study comparing famotidine
with cimetidine in the treatment of active duodenal ulcer disease.
Digestion. 42:86–92. 1989.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Kang JY, Guan R, Tay HH, Yap I, Wee A,
Math MV and Labrooy SJ: Low-dose cimetidine in the acute treatment
of duodenal ulcer. Comparison of a single nocturnal dose regimen
with a twice daily regimen. J Gastroenterol Hepatol. 5:669–674.
1990.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Double blind comparative study of
omeprazole and ranitidine in patients with duodenal or gastric
ulcer: A multicentre trial. Gut. 31:653–656. 1990.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Popovic O, Dzambas D, Tasic T, Bidikov V,
Jesenski T and Janosevic S: Omeprazole 20 mg o.m. vs. famotidine 40
mg h.s. in the treatment of duodenal ulcer. Multicenter
double-blind randomized trial. Gastroenterohepatoloski Arhiv.
9:26–34. 1990.
|
|
59
|
Cochran KM: Famotidine, ranitidine and
cimetidine in the treatment of duodenal ulcer: Two large
international studies. Eur J Gastroenterol Hepatol. 3:527–531.
1991.
|
|
60
|
Londong W, Barth H, Dammann HG, Hengels
KJ, Kleinert R, Müller P, Rohde H and Simon B: Dose-related healing
of duodenal ulcer with the proton pump inhibitor lansoprazole.
Aliment Pharmacol Ther. 5:245–254. 1991.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Delle Fave G, Annibale B, Franceschi M,
Quatrini M, Cassetta MR and Torsoli A: Omeprazole versus famotidine
in the short-term treatment of duodenal ulcer disease. Aliment
Pharmacol Ther. 6:469–478. 1992.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Hotz J, Kleinert R, Grymbowski T, Hennig U
and Schwarz JA: Lansoprazole versus famotidine: Efficacy and
tolerance in the acute management of duodenal ulceration. Aliment
Pharmacol Ther. 6:87–95. 1992.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Kumar TR, Naidu MU, Shobha JC, Reddy DN,
Subhash S, Chaubal C, Prasad R and Babu S: Comparative study of
omeprazole and famotidine in the treatment of duodenal ulcer.
Indian J Gastroenterol. 11:73–75. 1992.PubMed/NCBI
|
|
64
|
Lysy J, Karmeli F, Wengrower D and
Rachmilewitz D: Effect of duodenal ulcer healing induced by
omeprazole and ranitidine on the generation of gastroduodenal
eicosanoids, platelet-activating factor, pepsinogen A, and gastrin
in duodenal ulcer patients. Scand J Gastroenterol. 27:13–19.
1992.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Wang CY, Wang TH, Lai KH, Siauw CP, Chen
PC, Yang KC, Tsai YT and Sung JL: Double-blind comparison of
omeprazole 20 mg OM and ranitidine 300 mg NOCTE in duodenal ulcer:
A Taiwan multi-centre study. J Gastroenterol Hepatol. 7:572–576.
1992.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Ahmed W, Qureshi H, Zuberi SJ and Alam SE:
Omeprazole vs ranitidine in the healing of duodenal ulcer. J Pak
Med Assoc. 43:111–112. 1993.PubMed/NCBI
|
|
67
|
Misra SC, Dasarathy S and Sharma MP:
Omeprazole versus famotidine in the healing and relapse of duodenal
ulcer. Aliment Pharmacol Ther. 7:443–449. 1993.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Judmaier G and Koelz HR: Comparison of
pantoprazole and ranitidine in the treatment of acute duodenal
ulcer. Pantoprazole-Duodenal Ulcer-Study Group. Aliment Pharmacol
Ther. 8:81–86. 1994.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Lanza F, Goff J, Scowcroft C, Jennings D
and Greski-Rose P: Double-blind comparison of lansoprazole,
ranitidine, and placebo in the treatment of acute duodenal ulcer.
Lansoprazole Study Group. Am J Gastroenterol. 89:1191–1200.
1994.PubMed/NCBI
|
|
70
|
Porro GB, Lazzaroni M, Cardelli A,
Gasperoni S, De Berardinis F, Delle Fave G, Annibale B, Galeazzi R,
Novelli G, Mazzeo F, et al: Pantoprazole vs omeprazole in the
treatment of duodenal ulcer. Argomenti di Gastroenterologia Clin.
7:271–275. 1994.
|
|
71
|
Avner DL, Dorsch ER, Jennings DE and
Greski-Rose PA: A comparison of three doses of lansoprazole (15, 30
and 60 mg) and placebo in the treatment of duodenal ulcer. The
Lansoprazole Study Group. Aliment Pharmacol Ther. 9:521–528.
1995.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Beker JA, Bianchi Porro G, Bigard MA,
Delle Fave G, Devis G, Gouerou H and Maier C: Double-blind
comparison of pantoprazole and omeprazole for the treatment of
acute duodenal ulcer. Eur J Gastroenterol Hepatol. 7:407–410.
1995.PubMed/NCBI
|
|
73
|
Chang FY, Chiang CY, Tam TN, Ng WW and Lee
SD: Comparison of lansoprazole and omeprazole in the short-term
management of duodenal ulcers in Taiwan. J Gastroenterol Hepatol.
10:595–601. 1995.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Ekström P, Carling L, Unge P, Anker-Hansen
O, Sjöstedt S and Sellström H: Lansoprazole versus omeprazole in
active duodenal ulcer. A double-blind, randomized, comparative
study. Scand J Gastroenterol. 30:210–215. 1995.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Rehner M, Rohner HG and Schepp W:
Comparison of pantoprazole versus omeprazole in the treatment of
acute duodenal ulceration-a multicentre study. Aliment Pharmacol
Ther. 9:411–416. 1995.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Schepp W and Classen M: Pantoprazole and
ranitidine in the treatment of acute duodenal ulcer. A multicentre
study. Scand J Gastroenterol. 30:511–514. 1995.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Miszputen SJ, De PVM, Kondo M, Ferrari A,
Zaterka S, Eisig JN, Chinzon D, De M, Maguilnik I, Vieira FEF, et
al: Comparative multicentric study between omeprazole and
ranitidine in duodenal ulcer. GED. 16:127–134. 1997.
|
|
78
|
Papp J, Döbrönte Z, Juhász L and Lonovics
J: Evaluation of the effectiveness of pantoprazole and ranitidine
in the treatment of duodenal ulcer. Result of an international
multicenter study. Orv Hetil. 138:2863–2866. 1997.PubMed/NCBI(In Hungarian).
|
|
79
|
Bardhan KD, Crowe J, Thompson RP, Trewby
PN, Keeling PN, Weir D and Crouch SL: Lansoprazole is superior to
ranitidine as maintenance treatment for the prevention of duodenal
ulcer relapse. Aliment Pharmacol Ther. 13:827–832. 1999.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Dekkers CP, Beker JA, Thjodleifsson B,
Gabryelewicz A, Bell NE and Humphries TJ: Comparison of rabeprazole
20 mg versus omeprazole 20 mg in the treatment of active duodenal
ulcer: A European multicentre study. Aliment Pharmacol Ther.
13:179–186. 1999.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Dobrilla G, Piazzi L and Fiocca R:
Lansoprazole versus omeprazole for duodenal ulcer healing and
prevention of relapse: A randomized, multicenter, double-masked
trial. Clin Ther. 21:1321–1332. 1999.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Breiter JR, Riff D and Humphries TJ:
Rabeprazole is superior to ranitidine in the management of active
duodenal ulcer disease: Results of a Double-Blind, randomized North
American study. Am J Gastroenterol. 95:936–942. 2000.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Meneghelli UG, Zaterka S, de Paula Castro
L, Malafaia O and Lyra LG: Pantoprazole versus ranitidine in the
treatment of duodenal ulcer: A multicenter study in Brazil. Am J
Gastroenterol. 95:62–66. 2000.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Shim CS, Cho JY, Chung IS, Yang YS, Kim SW
and Choi MG: Rabeprazole 10 mg versus omeprazole 20 mg in the
treatment of duodenal ulcer: The Korean multicenter, comparative
trial. Korean J Gastrointestinal Endoscopy. 24:76–83. 2002.
|
|
85
|
Ji S, Kim HS, Kim JW, Jee MK, Park KW, Uh
Y, Lee DK, Song JS, Baik SK and Kwon SO: Comparison of the efficacy
of rabeprazole 10 mg and omeprazole 20 mg for the healing rapidity
of peptic ulcer diseases. J Gastroenterol Hepatol. 21:1381–1387.
2006.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Ho KY, Kuan A, Zaño F, Goh KL, Mahachai V,
Kim DY and Yoon HM: Randomized, parallel, double-blind comparison
of the ulcer-healing effects of ilaprazole and omeprazole in the
treatment of gastric and duodenal ulcers. J Gastroenterol.
44:697–707. 2009.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Wang L, Zhou L, Lin S, Hu H and Xia J: A
New PPI, Ilaprazole compared with omeprazole in the treatment of
duodenal ulcer a randomized double-blind multicenter trial. J Clin
Gastroenterol. 45:322–329. 2011.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Wang L, Zhou L, Hu H, Lin S and Xia J:
Ilaprazole for the treatment of duodenal ulcer: A randomized,
double-blind and controlled phase III trial. Curr Med Res Opin.
28:101–109. 2012.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Miwa H, Uedo N, Watari J, Mori Y, Sakurai
Y, Takanami Y, Nishimura A, Tatsumi T and Sakaki N: Randomised
clinical trial: Efficacy and safety of vonoprazan vs. lansoprazole
in patients with gastric or duodenal ulcers-results from two phase
3, non-inferiority randomised controlled trials. Aliment Pharmacol
Ther. 45:240–252. 2017.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Fan L, Xianghong Q, Ling W, Ying H, Jielai
X and Haitang H: Ilaprazole compared with rabeprazole in the
treatment of duodenal ulcer: A randomized, double-blind,
active-controlled, multicenter study. J Clin Gastroenterol.
53:641–647. 2019.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Wu HN: Comparison of different
combinations of triple therapy in the treatment of Helicobacter
pylori positive duodenal ulcer. Yunnan Med. 38:242–244.
2017.
|
|
92
|
Huang HY, Liu GF, Qi CX, Zhao YH and Wu J:
Comparison of the efficacy of proton pump inhibitor high-dose
combination and bismuth combination in the eradication of
Helicobacter pylori. Clin Focus. 37:230–233. 2022.
|
|
93
|
Shi RL: Evaluation of rational use of
proton pump inhibitors in 300 inpatients. Chin Modern Doctor.
60:92–95. 2022.
|
|
94
|
Li CY, Zhang J, Wang XH and Wang YN:
Investigation and analysis of proton pump inhibitors in 3005
hospitalized patients. Evaluation and Analysis of Drug Use in
Chinese Hospitals. 17:406–409. 2017.
|
|
95
|
Zhang J, Ge L, Hill M, Liang Y, Xie J, Cui
D, Li X, Zheng W and He R: Standard-dose proton pump inhibitors in
the initial Non-eradication treatment of duodenal ulcer: Systematic
review, network Meta-analysis, and Cost-effectiveness analysis.
Front Pharmacol. 9(1512)2018.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Huang YZ: Clinical effect of gastric
mucosal protector combined with proton pump inhibitor in the
treatment of peptic ulcer with hemorrhage. Chin Med Guide.
20:29–32. 2022.
|
|
97
|
Satoh K, Yoshino J, Akamatsu T, Itoh T,
Kato M, Kamada T, Takagi A, Chiba T, Nomura S, Mizokami Y, et al:
Evidence-based clinical practice guidelines for peptic ulcer
disease. J Gastroenterol. 51:177–94. 2016.PubMed/NCBI View Article : Google Scholar
|
